Byron Jones

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 8

Top Topics

Chronic Obstructive Pulmonary Disease

Decision Making

Top Venues

Pharmaceutical statistics

Clinical pharmacology and therapeutics

International journal of technology assessment in health care

Biometrical journal. Biometrische Zeitschrift

This page only lists publications with an associated author ORCID identifier.

Publications

Byron Jones, Mandy Ryan, Nigel S Cook, Florian S Gutzwiller
DEVELOPMENT OF A DISEASE-SPECIFIC HEALTH UTILITY SCORE FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE FROM A DISCRETE CHOICE EXPERIMENT PATIENT PREFERENCE STUDY. International journal of technology assessment in health care (2024)
Byron Jones, Mandy Ryan, Nigel S Cook, Florian S Gutzwiller
Development of a disease-specific health utility score for chronic obstructive pulmonary disease from a discrete choice experiment patient preference study. International journal of technology assessment in health care 40 (1) (2024)
Cornelia Dunger-Baldauf, Rob Hemmings, Frank Bretz, Byron Jones, Anja Schiel, Chris C Holmes
Generating the Right Evidence at the Right Time: Principles of a New Class of Flexible Augmented Clinical Trial Designs. Clinical pharmacology and therapeutics (2023)
Cornelia Dunger-Baldauf, Rob Hemmings, Frank Bretz, Byron Jones, Anja Schiel, Chris C Holmes
Generating the right evidence at the right time: Principles of a new class of flexible augmented clinical trial designs. Clinical pharmacology and therapeutics (2023)
Byron Jones, Bingbing Li, Morten Bagger, Alex Goodyear, Inga Ludwig
Response to the letter to the editor regarding our article 'statistical methodology for highly variable compounds: A novel design approach for the ofatumumab phase 2 bioequivalence study' https://doi.org/10.1002/pst.2233. Pharmaceutical statistics 21 (6) (2022)
Byron Jones, Bingbing Li, Morten Bagger, Alex Goodyear, Inga Ludwig
Statistical methodology for highly variable compounds: A novel design approach for the ofatumumab Phase 2 bioequivalence study. Pharmaceutical statistics 21 (6) (2022)
Johanna Mielke, Heinz Schmidli, Byron Jones
Incorporating historical information in biosimilar trials: Challenges and a hybrid Bayesian-frequentist approach. Biometrical journal. Biometrische Zeitschrift 60 (3) (2018)
Willi Maurer, Byron Jones, Ying Chen
Controlling the type I error rate in two-stage sequential adaptive designs when testing for average bioequivalence. Statistics in medicine 37 (10) (2018)